Methylprednisolone Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on 12/15/2021. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Sagent Pharmaceuticals
- Package NDC
- 25021-820-05
- Dosage Form
- Injection
- Presentation
- Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)
- Initial Posting
- 12/15/2021
- Revised Date
Reason
Shortage of an active ingredient